Sattar N - Search Results

1

Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm.

Robertson J, Peters MJ, McInnes IB, Sattar N. Robertson J, et al. Among authors: sattar n. Nat Rev Rheumatol. 2013 Sep;9(9):513-23. doi: 10.1038/nrrheum.2013.91. Epub 2013 Jun 18. Nat Rev Rheumatol. 2013. PMID: 23774906 Review.

2

Supraphysiological concentrations of estradiol in menopausal women given repeated implant therapy do not adversely affect lipid profiles.

Pirwany IR, Sattar N, Greer IA, Packard CJ, Fleming R. Pirwany IR, et al. Among authors: sattar n. Hum Reprod. 2002 Mar;17(3):825-9. doi: 10.1093/humrep/17.3.825. Hum Reprod. 2002. PMID: 11870144

3

C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study.

Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N; West of Scotland Coronary Prevention Study. Freeman DJ, et al. Among authors: sattar n. Diabetes. 2002 May;51(5):1596-600. doi: 10.2337/diabetes.51.5.1596. Diabetes. 2002. PMID: 11978661

4

Low triglyceride, not low cholesterol concentration, independently predicts poor outcome following acute stroke.

Weir CJ, Sattar N, Walters MR, Lees KR. Weir CJ, et al. Among authors: sattar n. Cerebrovasc Dis. 2003;16(1):76-82. doi: 10.1159/000070119. Cerebrovasc Dis. 2003. PMID: 12766366 Clinical Trial.

5

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study.

Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J. Sattar N, et al. Circulation. 2003 Jul 29;108(4):414-9. doi: 10.1161/01.CIR.0000080897.52664.94. Epub 2003 Jul 14. Circulation. 2003. PMID: 12860911

6

Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis.

Sattar N, McCarey DW, Capell H, McInnes IB. Sattar N, et al. Circulation. 2003 Dec 16;108(24):2957-63. doi: 10.1161/01.CIR.0000099844.31524.05. Circulation. 2003. PMID: 14676136 Review.

7

Inflammation and endothelial dysfunction: intimate companions in the pathogenesis of vascular disease?

Sattar N. Sattar N. Clin Sci (Lond). 2004 May;106(5):443-5. doi: 10.1042/CS20040019. Clin Sci (Lond). 2004. PMID: 14741042 Review.

8

Do pregnancy complications and CVD share common antecedents?

Sattar N. Sattar N. Atheroscler Suppl. 2004 May;5(2):3-7. doi: 10.1016/j.atherosclerosissup.2004.03.002. Atheroscler Suppl. 2004. PMID: 15121029 Review.

9

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial.

McCarey DW, McInnes IB, Madhok R, Hampson R, Scherbakov O, Ford I, Capell HA, Sattar N. McCarey DW, et al. Among authors: sattar n. Lancet. 2004 Jun 19;363(9426):2015-21. doi: 10.1016/S0140-6736(04)16449-0. Lancet. 2004. PMID: 15207950 Clinical Trial.

10

Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy?

Rodie VA, Freeman DJ, Sattar N, Greer IA. Rodie VA, et al. Among authors: sattar n. Atherosclerosis. 2004 Aug;175(2):189-202. doi: 10.1016/j.atherosclerosis.2004.01.038. Atherosclerosis. 2004. PMID: 15262174 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results